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ABSTRACT 
 
 Using magnetic resonance imaging, relaxation rate measurements were performed  
in cancer cells overexpressing a magnetotactic bacterial gene, MagA. Measurements of  
magnetic resonance relaxation rates in this expression system is important for optimizing cell  
detection and specificity, for developing quantification methods, and for refinement of gene- 
based iron contrast using magnetosome associated genes. We measured the total transverse  
relaxation rate (R2
*
), its irreversible and reversible components (R2 and R2
′
, respectively)  
and the longitudinal relaxation rate (R1) in MDA-MB-435 tumor cells. Clonal lines  
overexpressing MagA were cultured in the presence and absence of iron supplementation,  
and mounted in a spherical phantom for relaxation rate measurements at 3Tesla. In addition  
to MR measures, cellular changes in iron were evaluated by inductively-coupled plasma  
mass spectrometry. Values of R2
*
 and R2
ʹ 
were significantly higher (p < .01, accounting for  
multiple comparisons) in iron-supplemented, MagA- expressing cells compared to  
unsupplemented cells. R2
*
 provided the greatest absolute difference and R2
′
 showed the  
greatest relative difference, consistent with the notion that R2
′
 may be a more specific  
indicator of iron-based contrast than R2, as has been observed in brain tissue. R2 differences  
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between the supplemented and non-supplement MagA-expressing cells showed a trend  
(p < .05) toward significance. R1 differences between these conditions were not significant.  
For parental cells, no significant differences between iron-supplemented and unsupplemented  
cells were observed in any of the relaxation rates. The results highlight the potential of  
magnetotactic bacterial gene expression for detecting labeled cells.  
 
Keywords: Magnetic resonance imaging, MagA, relaxation rates, iron, cancer cells 
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Chapter 1 
1.1 Molecular Imaging and Image-Based Cell Tracking 
 The further development of molecular imaging techniques, involving the  
improvement and testing of unique tools and reagents as a means to detect molecular 
pathways in vivo, is a current area of research which is growing rapidly [1-4]. This type of  
imaging provides a non-invasive way of monitoring processes leading to disease, from  
diagnosis through therapy. Molecular imaging can potentially enable one to monitor cellular  
activity in terms of location, distribution and long term viability. Scientific accomplishments  
have been obtained through various imaging systems, such as bioluminescence and  
fluoresecence, computed tomography (CT), positron emission tomography (PET), single  
photon emission computed tomography (SPECT), ultrasonography (US), magnetic resonance  
spectroscopy (MRS) and magnetic resonance imaging (MRI). Each of these imaging  
modalities has its own advantages and disadvantages.  
 Of the various imaging platforms, MRI, has distinguished itself as a promising  
system. The strengths of MRI, the imaging modality used in this thesis, include the ability to  
image at any tissue depth [5] and to provide excellent soft tissue contrast with high spatial  
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resolution [6]. Since its introduction over 25 years ago, MRI has been applied to longitudinal  
studies [7, 8] and the repetitive monitoring of processes like therapeutic stem cell  
engraftment, cancer growth and metastasis, changes in pancreatic beta cell function during  
diabetes and cardiac cell activity after heart attack [9]. In spite of these strengths, MRI fails  
to track cellular and molecular activities as has been achieved in optical imaging using  
reporter genes such as the green fluorescent protein and luciferase [2, 10]. While these  
reporters may provide fine spatial and temporal information for cell microscopy, in vivo  
optical imaging of live animals is limited to superficial regions because of the absorption and  
scattering of light. Of the non-invasive in vivo imaging modalities, MRI has relatively high  
spatial resolution and allows long-term repetitive imaging, without using ionizing radiation.  
However, MRI fails to show high sensitivity compared to SPECT and bioluminescence  
imaging. In order to take advantage of MRI in image-based cell tracking, labeling of cells is  
required to improve bio-imaging at the cellular and molecular level [11].  
1.2 Cell Tracking using MRI 
 Progressive molecular imaging techniques cater to advanced and improved ways for  
quantitative cell tracking. In order to detect transplanted cells using MRI, cells need to be  
 3 
 
labeled with magnetic contrast agents. Initially most methods for tracking cells  
involved the use of exogenous labels, such as superparamagnetic iron oxide (SPIO)  
nanoparticles because of the high sensitivity of detecting these labeled cells [12, 13]. This  
high sensitivity is due to the large amount of SPIO iron that can be taken up. For example,  
single cell MRI detection has been accomplished in one study where the average iron content  
per cell was approximately 70 pg [14]. Gene based methods have also been under  
development to address one of the problems with SPIO nanoparticle labeling: dilution of the  
particle following repeated cell divisions. Another shortcoming of SPIO particles concerns  
their localization upon cell death. For example, macrophages engulf dead cells and may  
release the iron in a spatially and temporally different pattern than the original host cell. As a  
result of this, the free SPIO may remain in the body and show MR contrast which can be  
misleading [15]. In a report by Amsalem et al. it was shown that MRI signal voids were not  
from the SPIO labeled transplanted cells but instead from the cardiac macrophages which  
took up the free SPIO [16]. Haacke et al. also showed that free SPIO released by dead cells  
was taken up either by macrophages or nested in the local tissue [17]. To effectively monitor  
cell location and activity it is essential to be able to specifically detect live cells. Various  
methods of overcoming the limitations of cell tracking with exogenous cell labeling have  
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been adapted including the use of endogenous or gene-based labels.  
1.3 MRI using Gene-Based Label   
 To circumvent the problems associated with cell tracking using SPIO nanoparticles,  
described above, genetic engineering methods have been employed to overexpress genes  
involved in the transport and storage of iron thereby leading to an increase in the intracellular  
level of iron [9]. Various methods and proteins dealing with iron have been studied for their  
proficiency as MR contrast agents, along with those recognized for their primary function in   
mammalian iron homeostasis: iron response elements [18], transferrin receptor [19] and  
ferritin subunits [20]. Part of the challenge in adapting iron binding proteins for use in  
generating MR contrast relates to the elaborate control of iron homeostasis in mammalian  
cells [21] and the manner in which this may fluctuate in response to changes in physiological  
state [22]. The development of these gene-based contrast agents for MRI leads to the  
possibility of  imaging reporter gene expression and pathology in transgenic animals [23].  
Although the evolution of gene-based, MR contrast for cell tracking and the MRI  
methodology used for its detection is progressing it requires further development. 
 Research in the last decade has revealed that iron biomineral formation is a  
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phenomenon that can occur naturally in the animal kingdom. Magnetotactic bacteria are an  
extraordinary example of how single cells may synthesize and compartmentalize an iron  
biomineral, magnetite (Fe3O4), in  a membrane-enclosed magnetosome [24-26] and harness  
its magnetic properties [27]. Although an understanding of the molecular nature of the  
magnetosome is not yet complete, many applications making use of its effect on the MRI  
signal have been carried out [28, 29]. A more complete understanding of which genes are  
essential for the synthesis of the basic magnetosome compartment and for the manipulation  
of select magnetosome features, would permit the versatile use of this structure in the  
generation of MR contrast for pre/clinical imaging [9]. 
 Several genes involved in the formation of magnetosome and magnetotactic bacteria  
have been studied. Among these genes, MagA, was one of the first to be identified and has  
been partially characterized as an iron transport protein [30]. MagA, an integral membrane  
protein, is potentially involved in the active transport of the large quantity of iron required  
to support magnetosome formation [31]. As expected, MagA-expression results in iron  
accumulation in the cell [32]. As a result, this leads to a change in contrast detectable by MRI 
[33, 34]. Additionally, the estimated iron per cell using this gene-based contrast is close to  
0.6 pg/cell [34] and is approximately 100 x lower than the SPIO values provided earlier [14]. 
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 There are some advantages and disadvantages of using cells manipulated to  
overexpress MagA. These advantages are (i) Longitudinal imaging over time can be  
performed – ideally no dilution of the label occurs with cell division if it is assumed that iron  
levels in extracellular fluid are sufficiently high. Keeping these iron levels high enough may  
require iron supplementation of drinking water for animals. (ii) Working with MagA may  
lead to the development of a reporter gene, i.e., a gene construct capable of monitoring   
transcription factor activity. Disadvantages of MagA (or other gene-based iron labeling) 
 include the lower sensitivity due to lower iron uptake (approximately 100 times lower  
compared to SPIO particles) and the complexity of cell preparation. 
 Recently, contrast due to overexpression of either MagA or the modified ferritin  
subunits (heavy and light chain, HF + LF), lacking iron response elements to enable  
continuous expression, were compared in a model of tumour growth from transplanted cells  
[35]. These studies suggest that magnetotactic bacterial genes, including magnetosome  
genes, may be effectively used in the future for reporter gene expression for molecular MRI.  
1.4 Role of MagA in MRI  
  Cells with iron-based contrast agents are difficult to differentiate from  
anatomical features represented as dark regions on MRI because hypointense signals are  
 7 
 
generated when these contrast agents are used [36]. In this scenario, MagA overexpression  
may be particularly useful in tracking breast cancer metastasis in the white matter of brain  
[37]. Recently, a group characterized the temporal pattern of contrast due to the constitutive  
expression of MagA [35] to utilize this technique in future for reporter gene expression in  
tumor xenografts. 
 Previous measurements of MRI relaxation times in MagA-expressing mammalian  
cells have been carried out. Manipulation of T2 relaxation time (refer to section 1.5.2) for  
cell detection was assessed in 293FT cells using doxycycline induced expression of MagA,  
cloned from M. magnetotacticum strain MS-1[33]. The effect of varying concentrations of  
iron supplement on T2 relaxation rate was examined on a 3T MR scanner using a Carr- 
Purcell-Meiboom-Gill (CPMG) sequence. The relaxation rate of MagA-expressing cells  
showed that the measurement of R2 (1/T2) depended on the concentration of iron (ferric  
nitrate) in the culture medium. In this study by Zurkiya et al., they showed that induction of  
MagA-expression (by doxycycline) was coordinated with the increase in R2.  This not only  
shows that a molecular interaction can stimulate changes in R2 through a genetic mechanism  
but also provides strong support for the application of  gene-based iron contrast. In this cell  
line expressing MagA, values of R2 varied roughly between 6-9 s
-1
. 
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 In 2011, another magnetotactic bacterial gene, Mms6, was reviewed as an MRI  
reporter [38]. This small protein associated with Mms6 gene, acidic in nature and showing  
high affinity for iron ions [39], was used in 293T cells for investigating the same R2  
relaxation rates [40]. The response pattern of the R2 relaxation rate to the iron-supplemented  
Mms6-expressing cells was similar to that of the MagA-expressing cells, but R2 was lower in  
value (4-6 s
-1
) in the identical cell line. Although Mms6 has a potential as a reporter gene,  
further work is required to demonstrate its efficiency in producing MR contrast.  
 In another assessment of MR intracellular contrast, MagA cloned from strain AMB-1  
was compared to a mutated form [33]. Mouse neuroblastoma (N2A) cells were transfected  
with MagA, mutant or vector DNA, cultured in the presence of 250 μM ferric nitrate and  
immobilized in gelatin phantoms for imaging at 11T. Based on the image analysis the authors   
reported that MagA-expressing cells can produce signal contrast over mutant or vector  
controls detectable by MRI. In this same report, the potential of MagA- expressing cancer  
cells to grow and generate intracellular contrast in vivo was evaluated on a 3T MRI system.  
Human MDA-MB-435 cells were transfected with MagA and transplanted subcutaneously  
into the hind limb of immune-deficient mice. The results of this imaging study not only  
revealed that tumours formed from MagA-expressing cells generated hypointense signal  
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regions compared to the parental control but also showed that MagA-expression maintained  
the biological programming of cancer cells.  
 Recently, it has also been shown that MR contrast can be observed when the  
overexpression of MagA from AMB-1was compared to that of modified, mammalian ferritin  
subunits [35]. In a mouse model of tumor growth, transplanted cells were imaged over 5  
weeks in a repetitive manner and compared to the parental cell xenograft. Both MagA- and  
HF+LF-expressing tumors provided contrast enhancement.  Moreover, MagA-derived  
contrast exhibited greater contrast to noise ratio than HF+LF-expressing tumors, particularly  
in the immediate days post-injection, indicating a role for select magnetotactic bacterial  
genes in preclinical molecular imaging.  
 Despite the fact that very little is recognized regarding the handling of MagA activity  
in mammalian cells and whether or not MagA activity can be coordinated with precise  
location of its contrast signal, quantitative measures of iron contrast, such as relaxation rates  
(see section 1.6), can be of great value in localizing iron-loaded cells in the developing  
tumor. Relaxation rates provide an objective means for quantifying our observations. Also,  
such measures may in the future be utilized in developing methods for estimating the number  
of cells in each voxel. 
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 Before discussing the specific MRI measures used in this thesis, some of the basic  
principles of MRI will be briefly presented. Since MRI involves creating images of nuclear  
magnetic resonance (NMR) signals, MRI will be discussed after describing the basics of  
NMR. 
1.5 Nuclear Magnetic Resonance  
 1.5.1 Basics of NMR 
 The nature of NMR is based on the interactions of nuclear spins with an external  
magnetic field. In the classical view, protons are spinning charged particles producing a  
small magnetic moment [41]. They possess spin, a fundamental property of nature. Protons  
are fermions or spin ½ particles. They have spin angular momentum,  ⃗, which is associated  
with a magnetic diploe moment,  ⃗ that is oriented along the spin axis and expressed as  
      ⃗⃗ =   ⃗⃗       (1.1) 
where , known as the gyromagnetic ratio, is a nuclei specific constant. For protons  
(/2) = 42.576 × 106  Hertz per Tesla (Hz/T) [41].  
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Figure 1.1. Proton spin and its relation to magnetic moment 
 Magnetic resonance imaging is based on detecting NMR signals from hydrogen  
nuclei (single proton), which are the most abundant nuclei present in the body [41]. In  
particular it is hydrogen in water (or fat) that gives rise to most of these signals.  
 The sum of all nuclear magnetic moments in a given volume is known as the nuclear 
magnetization ( ⃗⃗⃗). In the context of MRI, ⃗⃗⃗ usually refers specifically to the nuclear  
magnetization from protons in water (or fat). (Signals from hydrogen nuclei in  
macromolecules, cell membranes etc. typically decay away too quickly to observe with  
conventional MRI.) In the absence of an external magnetic field, the net magnetization is  
zero. This is because all the spins are randomly oriented and as a result their magnetic  
moments cancel out. If a large external magnetic field (  ⃗⃗⃗⃗⃗) is present, the nuclear  
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magnetic moments partially align with it. Some of the spins align with their z-component  
parallel to   ⃗⃗⃗⃗⃗ while others align antiparallel to   ⃗⃗⃗⃗⃗. However, there are slightly more spins  
aligned parallel than antiparallel (difference on the order of 1 in 10
6
) to the direction of B0  
giving rise to the net magnetization (M) along this direction (z-direction). 
 In the classical picture, the spins’ magnetic moments precess (clockwise) around the  
direction of the external magnetic field at a frequency     , known as the resonance or  
Larmor frequency, determined by  
                     (1.2) 
 Since the x, y components of these magnetic moments cancel, the total magnetization, 
  ⃗⃗ ⃗⃗ ⃗⃗  is in the direction of   ⃗⃗⃗⃗⃗, [42]. This is known as the “equilibrium state” of the  
magnetization (Figure 1.2).  
 
Figure 1.2. Magnetization in equilibrium state.  ⃗⃗⃗⃗⃗⃗⃗ is parallel to the external magnetic 
field  ⃗⃗⃗⃗⃗⃗   and is in equilibrium along the field 
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 In order to produce an NMR signal the magnetization must be forced away from  
equilibrium. In the classical description when a torque is applied to the magnetization M0, it  
tips away from its initial position (Figure 1.3), parallel to the axis of B0 or z-axis. This  
rotation is accomplished using a time-dependent magnetic field known as a radiofrequency  
pulse (RF pulse), B1.  
  
Figure 1.3. Magnetization in a non-equilibrium state.  ⃗⃗⃗⃗⃗⃗⃗ is tipped away from the z-axis 
by an RF pulse 
 
 The tilted magnetization can be decomposed into two orthogonal components: a  
longitudinal or Z component and a transverse component on the XY plane (Figure 1.4).  
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Figure 1.4. Orthogonal components of the magnetization vector 
 Radiofrequency (RF) pulses create a time-varying magnetic field    ⃗⃗ ⃗⃗ ⃗⃗ , perpendicular  
to   ⃗⃗⃗⃗⃗ , oscillating at the Larmor frequency (or close to it). RF pulses can rotate the  
magnetization through any angle. In the case of a 90° RF pulse, the net magnetization is  
rotated into the x, y plane. As the magnetization is tipped away from the z-axis it begins to  
rotate about this axis at the Larmor frequency and this continues following the pulse. The  
rotating magnetization (magnetic field) induces a voltage signal in a nearby radiofrequency  
coil (antenna). 
 As soon as the RF pulse ceases, the system or the excited proton spins return from the 
unstable state to an equilibrium state. This return of the magnetization to its equilibrium  
position is termed “Relaxation”. There are two components to relaxation: the decay of Mxy  
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and the return of Mz to its equilibrium state.  
 1.5.2 Transverse Relaxation   
 The return of Mxy to equilibrium or zero value is called transverse relaxation. This  
decay is in some cases, an exponential decay process and is characterized by a time constant  
known as T2
*
 or the transverse relaxation time or as a rate R2
*
(1/T2
*
).  This decay is due to  
dephasing of the magnetic moments.  For example, when a proton spin feels a strong local  
magnetic field in the direction of B0  it will precess faster than average while a proton spin  
that feels a local magnetic field in the direction  opposite to B0 will precess slower than  
average and these magnetic moments will get out of phase leading to overall signal decay.  
There are various sources of transverse magnetization decay including nuclear spin-spin  
interactions  and local magnetic field variations over distance scales from microscopic to  
macroscopic. For example iron particles create spatially non-uniform magnetic fields ranging  
over micron or tens of micron distance scales, intermediate between dipolar magnetic fields  
(angstroms to nanometers) and the macroscopic magnetic field variations (mm to cm).  
 During the transverse magnetization decay a second RF pulse that rotates the  
magnetization though 180° can be applied and will have the effect of partially reversing the  
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dephasing described above. Thus there are reversible and irreversible contributions to R2
*
.   
In this thesis we will denote the irreversible and reversible components as R2 (1/T2) and R2
ʹ  
(1/T2
ʹ 
) respectively, where  
   R2
*
   = R2 + R2
ʹ  
    (1.3) 
Some authors define R2 as being only due to the nuclear spin-spin interactions.  However,  
other sources of microscopic magnetic field variation, such as that due to iron particles can  
lead to partially irreversible transverse magnetization decay due to the effects of water self  
diffusion. (Some authors would consider this diffusion effect as an “apparent” contribution to  
R2.)  In particular, a water molecule will likely be in a different location during the  
dephasing are rephrasing periods (before and after the 180°, respectively), and hence, the  
dephasing will not be completely rephased. Cellular iron influences both R2 and R2ʹ with  
the degree of reversibility depending on spatial distribution of particles. 
 Nuclear spin-spin relaxation is governed by the interactions between proton spins and  
their surroundings. In general, each of the proton spins creates a non-uniform local magnetic  
field distributed roughly over molecular distance scales. As a result a given nucleus can  
experience widely varied local magnetic field values based on the location and orientation of  
its neighbours.   
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 In solids, where the local field distribution is almost static, the T2 decay times are  
on the order of microseconds. In liquids, due to rapid motion of the water molecules, the  
local magnetic field experienced by each proton changes rapidly thereby reducing effect of  
the local magnetic fields leading to longer decay times, on the order of milliseconds.  
 1.5.3. Longitudinal Relaxation 
 The regrowth of Mz along z-axis takes place through longitudinal or spin-lattice  
relaxation, characterized by a time constant T1 or the longitudinal relaxation time.  
 Transitions of excited proton spins to the equilibrium position are due to the local  
magnetic fields experienced by a single nucleus (1H for water) from its neighbouring nuclei  
(1H) including neighbor on the same water molecule as well as the nuclei (1H) of nearby  
water molecules. This local magnetic field fluctuates rapidly because of the rapid motion of  
the water molecules. The fluctuations are typically spread out over the spectrum from low to  
very high, much higher than the Larmor frequency (the correlation time for water is roughly  
on the order of 10
-12
 sec).  It is the frequency component at the Larmor frequency that leads  
to T1 relaxation.   
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1.5.4. Nuclear Magnetic Resonance Signals  
 The free induction decay (FID) is the signal obtained following a single RF pulse.  
The decay of this signal corresponds to the T2
*
 decay of the magnetization described above.  
The amplitude of this generated signal decays to zero, without losing energy to the  
environment. In tissues the FID typically has a duration of tens of millisecond.  
 A spin echo sequence uses a 90° RF pulse followed by a 180° RF pulse. The 90°  
pulse is applied to tip the total magnetization M0 into the transverse or XY plane where the  
spins dephase naturally. Then after a certain time period a 180° pulse is applied in order to  
partially refocus (only the static part) of the dephased spins. The spins at this point maintain  
the same precessional frequencies with reversed phase angles. The time period between the  
90° and 180° RF pulses is represented by TE/2 which is half of the echo time (TE). After a  
certain time, equal to the delay between 90° and 180° pulse, the spins partially rephase  
forming an echo (Figure 1.5).  
 19 
 
 
Figure 1.5. Spin echo pulse sequence. 180° RF pulse following a 90° RF pulse refocuses 
the spins to create the echo of the signal called the spin echo (SE) at the echo time (TE). 
 
1.6 Magnetic Resonance Imaging (MRI) 
 Magnetic resonance imaging (MRI) signals are similar to NMR signals but  
MRI also involves localization of this signal which is accomplished with magnetic field  
gradients. There are three field gradients, one in each of the three directions, x, y and z.  
The magnetic field gradient refers to an additional magnetic field that varies linearly in one  
of the directions (typically the gradient or slope has a maximum value on the order of tens of  
mT/m). 
 MRI pulse sequences are comprised of RF pulses and gradient magnetic fields.  
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The order, amplitudes, shapes, and spacing of both RF and gradient waveforms are included  
in each pulse sequence. Here we will consider conventional spin-echo (SE) and  
gradient-echo (GE) pulse sequences as these are relevant to the experiments carried  
out for this thesis.  
 1.6.1 Spin-Echo Imaging 
 In conventional spin echo imaging (Figure 1.6) the RF pulses are similar to those in  
nuclear magnetic resonance (NMR) except that they are slice selective in the case of two- 
dimensional (2D) acquisitions. RF pulses combine with a gradient to generate a rotation  
angle typically between 0° and 90° for protons that are located within a slice of tissue  
(typically a few mm thick). Localization within the plane of the image is accomplished by  
frequency encoding in one direction and phase-encoding in the orthogonal direction. The  
frequency encoding gradient when applied in one direction creates linear variation of  
precession frequencies along that direction which encodes the positions of the resonating  
spins based on the frequency of their signals. The phase encoding gradient, is utilized to  
impart a specific phase angle to the transverse magnetization. This angle depends on the area  
under the phase encoding gradient lobe and the position of the spins along the phase  
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encoding direction. Phase encoding is accomplished by repeating the signal acquisition (Ny  
times, see Figure 1.6) while incrementing the area under the phase encoding lobe each time.  
The spatial information is encoded in the phase of the signals. In acquiring a SE image the  
segment shown in Figure 1.6 is repeated Ny times, where Ny, is the number of phase  
encoding steps (equal to the matrix size of the image in the phase encoding direction). The  
time between each of these segments is called the repetition time TR. 
 
Figure 1.6. Pulse sequence diagram for conventional spin-echo imaging.  
 
The amplitude of a simple spin-echo signal, in the limit where TR >> TE, is given by the  
following equation: 
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    (     )                           (      )   (1.4) 
However, a closer approximation is given by replacing TR by TR – TE, given by [43] 
   (     )               (     )           (      )            (1.5) 
 1.6.2 Gradient-Echo Imaging 
 The GE sequence is simpler than SE sequence and uses a single RF pulse followed by  
a gradient pulse to generate the echo. The scan times for GE sequences can be much shorter  
than for SE sequences because short TR times can be used if small flip angles are employed  
for excitation. In GE sequences, gradient reversal is used to form the gradient echo [45, 46]  
instead of the 180° refocusing pulse, used for echo formation in the SE sequence. Gradient  
reversal is applied with the frequency encoding gradient and hence this gradient performs the  
function of echo formation and spatial encoding along one dimension. The amplitude of the  
single gradient-echo signal (Figure 1.7) is similar to the FID signal assumed to be  
exponential, given by 
    (     )             (      )       (      
 ) (1.6) 
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Figure 1.7. Simple single gradient echo pulse sequence. Excitation pulse is followed by a 
gradient pulse which makes the spins to rephase and form a gradient echo.  
 
 The multi-echo gradient echo sequence is similar to the single-echo gradient echo  
sequence except that in this case signals at multiple TE’s are acquired within each TR period.  
 1.6.3 Inversion Recovery Spin-echo Imaging  
 The inversion recovery spin-echo sequence, is applied in my thesis for the  
measurement of R1 (1/T1). The pulse sequence is similar to that of the spin-echo, except that  
an additional 180° RF pulse is included prior to the 90° RF pulse. This initial 180° pulse  
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inverts the z-magnetization and hence is referred to as an inversion pulse. The time delay  
between the inversion pulse and the 90° pulse is known as the inversion time (TI).  
The inversion recovery spin-echo signal is given by  
              (  )              (     )       (      )      (      )          (1.7)  
1.7 Thesis Overview 
 There is a great deal of interest in developing magnetic resonance imaging (MRI)  
methods to monitor the location of cancer cells as well as their molecular activity in animal  
models of tumor growth and metastasis. Labeling cancer cells with iron nanoparticles  
provides a means of detection and localization. Iron particles create a microscopically non- 
uniform magnetic field, which in turn, influences fundamental MRI parameters called  
relaxation rates.  
 The most common method of iron-based cell labeling involves the introduction of  
exogenous superparamagnetic iron oxide nanoparticles. Although this provides high  
sensitivity for cell detection, the potential for long-term monitoring is limited due to  
degradation, dilution of the label during cell division and lack of inherent biological activity.  
Alternatively, gene-based contrast imparts endogenous magnetic characteristics to cells, thus,  
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creating a tracking system suitable for long-term, repetitive imaging of cellular function,  
including migration, mitosis and differentiation. In mammalian cancer cells, Goldhawk et al.  
[33] and Zurkiya et al. [34]  have previously demonstrated that expression of MagA, a  
putative iron transport protein from magnetotactic bacteria, leads to observable alterations in  
the MR signal.  
 The goal of my work was to quantify the effect of MagA -based iron labeling on  
MRI relaxation rates in order to provide insight into designing methods in the future for  
tracking these cells in-vivo. As mentioned earlier, both R2 and R2
*
 are influenced by iron  
and other tissue properties. However, studies related to R2
ʹ
 measurements in tissues showed  
that R2
ʹ
 was more characteristic of iron content than R2 [47]. Hence, the work in this thesis  
also includes assessing R2
ʹ 
 as a measure for detecting these labelled cells. My hypothesis is  
that R2
ʹ
 will provide a stronger indicator to detect iron supplementation in MagA  
samples and will correlate more strongly with iron content as compared to other relaxation  
rates. The experiments are carried out using MDA-MB-435 cells, a highly metastatic and  
aggressive cell line that was genetically engineered to overexpress MagA, in order to  
generate gene-based contrast. 
 In Chapter 2, an imaging design, involving quantification of the MRI signal  
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changes associated with cellular iron uptake by MagA-expressing cells has been applied  
to track gene-based iron-labeled cells. This quantification is based on measuring the MRI  
relaxation rates (R2
*
, R2, R2
ʹ
 and R1) in cultured MagA-expressing cells and in the  
untransfected parental cell line (MDA-MB-435), as a control. Using 3 Tesla (T) MRI and  
gelatin phantoms, my thesis demonstrates how the relaxation rates vary as a function of iron  
supplementation. Results are also examined in light of elemental iron content to reflect the  
degree of iron uptake.  
 In Chapter 3, the findings in chapter 2 are highlighted to address the efficiency of a  
single magnetotactic bacterial gene as an MR contrast agent, subject to genetic control. A 
summary of the findings along with future directions of this research are also provided. 
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Chapter 2 
2 Relaxation Rate Measurements in MagA-expressing Cancer 
Cells  
 
 For the work presented in this chapter I would like to acknowledge Kimberley Lam  
Tin Cheung and Sarah Donnelly for their contribution in performing BCA protein assays,  
the Laboratory for Geochemical Analysis within the Department of Earth Sciences at  
Western for performing iron analysis and Dr. Donna Goldhawk for her coordination in the  
analysis of cellular iron. All other procedures including cell phantom preparation, MR  
acquisition, data analysis and statistical analysis were performed by Anindita Sengupta. 
2.1 Introduction 
 This chapter presents an investigation of the transverse (R2*, R2 and R2') and  
longitudinal (R1) relaxation rates in MagA-expressing MDA-MB-435 cells measured with  
3 Tesla (T) MRI. These measurements provide quantitative information on the influence of  
the iron label on the MRI signals. In addition, elemental iron content measurements are  
presented and related to the MRI results. The findings highlight the utility of a single  
magnetotactic bacterial gene as an MR contrast agent. The potential for further  
improvements in MR detection of gene-based contrast upon a more complete representation  
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of the magnetosome compartment is predicted. 
2.2 Methods 
 2.2.1 Cell Culture 
 The cell lines used for these experiments consisted of human MDA-MB-435 in the  
form of a clonal population previously transfected with MagA and stably expressing this  
gene[1]. Cells were kept in culture for approximately 3 months. 
 Cells were cultured in low glucose Dulbecco’s Modified Eagle Medium  
supplemented with 10% fetal bovine serum and 0.5% penicillin/streptomycin. Iron- 
supplemented cells were prepared by incubation with medium containing 250 μM ferric 
nitrate  (Sigma-Aldrich, Oakville, Canada) for at least 5 days. All cell culture reagents were  
purchased from Life Technologies (Burlington, Canada) unless otherwise  noted. 
 Each cell type was grown as a monolayer on 100mm-plates. Stable expression of a 
MagA clone from pcDNA3.1Zeo(+) was obtained with 800 μg/ml Zeocin. The cultures were  
incubated at 37°C  until the cells reached 90-100% confluency at which time they were   
amplified onto 150mm-culture dishes. At harvest, cells were washed 3 times with  
phosphate-buffered saline pH 7.4 (PBS) , a physiological salt solution containing NaCl, KCl,  
Na2HPO4 and KH2PO4 in concentrations of 137, 2.7, 10 and 2 mmol/L respectively, to  
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remove medium and the extracellular iron supplement. All cell types were harvested from  
150 mm plates into centrifuge tubes by gentle trituration and were subjected to three cycles  
of centrifugation at 400xg (where “g” stands for relative centrifugal force) for 5 min at 15˚C  
during the PBS washes. Cells were then counted using a hemacytometer. 
 2.2.2 Phantom Preparation 
 Approximately 50-60 million cells of each type were placed in the wells from a 96- 
well break-apart plate (Nunc, Rochester, U.S.A.). Each well of inner diameter 6 mm and  
height 10 mm was centrifuged at 400 × g and for 5 min. to form a compact pellet  
approximately 6 mm in height. Cell pellets were overlaid with 1% gelatin/PBS and  
embedded in one hemisphere of a 9cm spherical phantom filled with 4% gelatin/PBS. A  
spherical-shaped phantom was used to minimize macroscopic magnetic field 
inhomogeneities which would interfere with accurate R2
'
 measurement. Samples  
consisted of either parental or MagA-expressing cells, cultured in the presence and 
absence of iron supplementation. To form the spherical gelatin phantom, the empty  
hemisphere was filled with 2% gelatin/PBS and placed on top of the half containing cell  
samples. To avoid susceptibility artifacts at the interface, air was excluded using a layer of  
parafilm. Figure 2.1 illustrates the phantom set-up used for relaxation rate measurements. 
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Figure 2.1 Cell Phantom for relaxation rate measurement 
 
 2.2.3 Relaxation Rate Measurements 
 Phantoms were scanned on a 3T Biograph mMR (Siemens AG, Erlangen,  
Germany) equipped with an actively shielded whole-body gradient system (with maximum  
gradient strength and slew rate of 45mT/m and 200T/m/s, respectively). A 15-channel knee  
coil was used for radiofrequency (RF) excitation and signal reception.  
 Image-based measurements of relaxation rates (R1, R2, R2
*
) were performed using  
the sequences and parameters provided in Table 1. 
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Table 1. Sequences and parameters used for measuring relaxation rates. 
 
Relaxation 
Rates 
Sequence TE 
 (ms) 
TR  
(ms) 
TI (ms) Matrix Flip 
Angle 
R2 Single-
echo 
Spin-echo 
13-300 
(9 TE values) 
*
1000 ˗ 192 × 192 90° 
 R2
*
 Multi-echo 
Gradient-
echo 
6.12-80 
(9 echoes) 
1000 ˗ 192 × 192 60° 
R1 Inversion-
recovery 
spin-echo 
13 4000 22-3900 
(6 values) 
128 × 128 90° 
*Note: For the single spin-echo sequence rather than fixing TR, the value of TR-TE was  
fixed ( [2] and equation (1.5)). 
The slice thickness was 1.5 mm and the field of view (FOV) was 120 mm for all the images.  
Voxel dimensions were 1.5×0.6×0.6 mm for R2 and R2
*
 acquisitions and 1.5×0.9×0.9 mm  
for R1 acquisitions.  
 MRI data were collected from 11 experiments where each experiment includes cell  
harvest, phantom preparation and the MRI scan. Typically the phantom for each experiment  
included four separate samples (i.e. each in a nunc well). In two experiments all cell 
samples, from each of the four groups [ parental(P),  iron-supplemented parental (P+Fe),  
MagA-expressing (MagA) and iron-supplemented MagA-expressing (MagA+Fe)] were  
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imaged together. Whereas the phantom contained only MagA+Fe and MagA-Fe samples for  
six of the experiments and it contained only P+Fe and P-Fe for three experiments. 
 Image processing and analysis were performed using commercial software tools.  
With the aid of MATLAB 7.9.0 (R2010b) a region of interest (ROI) was selected in each  
well to include the maximum number of voxels (approx. 30-50), excluding ones adjacent to  
the wall of the well. R2, R2
*
and R1 were determined with least square curve fitting (Sigma  
Plot 10.0.inc) of the mean ROI signals using equations 1.5, 1.6 and 1.7 in Chapter 1 as  
appropriate where the absolute value of equation 1.7 was used. R2' was obtained by  
subtraction (R2
*
-R2) (refer to equation 1.3 in Chapter 1).  
 2.2.4 Protein and Trace Element Analysis    
 Samples were sent to the Analytical Services Laboratory of Surface Science  
Western at Western University (London, Canada) for trace element analysis of iron and zinc  
using inductively-coupled plasma mass spectrometry (ICP-MS). To prepare samples for trace  
element analysis and protein quantification, cells were cultured as described above for MRI  
experiments and were harvested based on the confluency of 150mm-culture dishes a day or  
two before or after the actual day of MRI scan. Cells were then lysed in  
radioimmunoprecipitation assay (RIPA) buffer/protease inhibitor cocktail, such that  
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approximately 10 million cells were solubilized per ml of lysis solution. The total  
protein from lysis of these cultured cells was quantified using the bicinchoninic acid assay  
(BCA assay) [3]. Zinc provided a measure of cellular redox status as well as a point of  
comparison to amount of iron. Iron content was then normalized to quantity of protein as  
determined by the BCA assay . Over the course of relaxation rate measurements, iron content  
was periodically evaluated in cultured cells. 
 2.2.5 Statistical Analysis  
 Relaxation rate means, standard deviations (SD) and standard errors of the mean  
(SEM) were calculated for all group values. We then compared each cell type (parental and 
MagA), group mean relaxation rates (R2
*
, R2, and R2
'
) between runs, with versus without 
iron supplementation, using the independent sample t-test. We performed analysis of  
variance (ANOVA) on the absolute difference values obtained by subtracting mean  
relaxation rate values from the respective rank values between groups based on cell type and  
iron supplementation. The result showed no significant difference between the mean values.  
This was done to test the homogeneity of variance for our non-parametric data. The non- 
parametric Kruskal-Wallis test was then used to compare all runs of relaxation rates with iron 
versus all runs without iron, combining data from both cell types. Since there is no 
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accepted method for determining the statistical interaction between two variables with a non- 
parametric test a parametric analysis was also performed. (It is the interaction between iron  
condition (iron supplemented vs unsupplemented) and cell type (parental vs MagA) that is of  
most importance in this study). The parametric test, Two-way ANOVA was run to obtain the  
main effects and the interaction between the variables. All tests were two-tailed and SPSS  
version 20.0 was the statistical package used. Considering the effects of multiple  
comparisons, p < .01 was considered as significant. This was based on having 6 comparisons  
and rounding off the value 0.05/6 to 0.01. Although there are 4 parameters (R2, R2
ʹ
, R2
*
 and  
R1) only 3 are independent (R2, R2
ʹ
 and R2
*
 have only 2 independent parameters) so there  
are really only 3x2 = 6 comparisons rather than 4x2 = 8 comparisons. 
2.3 Results 
 2.3.1 Relaxation Rates  
 Representative spin-echo images of the phantom showing wells containing 
 parental and MagA-expressing cells are illustrated in Figure 2.2A. Part B of this figure 
displays the unnormalized signal decay curves with respect to TE for iron-supplemented  
MagA-expressing and parental samples. The symbols represent the mean signal intensities  
within regions of interest including most of the voxels in each well as described under 
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methods. Figure 2.2B shows faster signal decay for iron-supplemented MagA- 
expressing cells when compared to the iron-supplemented parental cells. 
 
Figure 2.2 Signal decay curves. Representative data indicate the influence of echo time 
(TE) on signal decay. (A) Single-echo spin echo (SE) images show sample wells in cross 
section at 3 different TE values (13, 100 and 300 ms): 1, parental (P); 2, MagA (A); 3, iron-
supplemented MagA (A+Fe); 4, iron-supplemented parental (P+Fe); and 5 polystyrene 
marker for reference. Samples along the bottom row are combinations of MagA-expressing 
and parental cells. (B) R2 relaxation curves are shown for iron-supplemented samples. 
Symbols indicate the mean signal intensity within a ROI at each TE. Best fit points are joined 
by splines to represent an exponential decay. 
  
 As expected, R2
*
 representing the total transverse relaxation rate (comprised of the  
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reversible component R2
ʹ
 and the irreversible component R2), shows higher decay rate of  
signal intensities than its components (Figure 2.3).    
 
Figure 2.3 Comparison between (a) R2* and (b) R2 relaxation curves for parental and 
MagA-expressing cell samples. The R2  relaxation curve is the same as Figure 2.2(B), 
except that it only includes the first 80 ms of the decay for comparison with the R2* curve 
(a). The R2* curves show a greater difference between the MagA-expressing and parental 
cells. 
  
Figure 2.3, demonstrates that R2
*
 shows a stronger difference between MagA+Fe and  
Parental+Fe than does R2.  
 Transverse relaxation rates, R2, R2
*
 and R2
ʹ, all were notably different in  
iron-supplemented cells overexpressing MagA. For each relaxation rate, significant main  
effects for the iron condition were found with both two-way ANOVA and Kruskal-Wallis  
tests (Figure 2.4). More importantly, the ANOVA provided a significant interaction between  
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iron condition and “cell type”, more specifically between iron-supplemented vs.  
unsupplemented and MagA-expressing vs. parental. 
 The independent sample t-test showed that there was no significant difference in  
MR relaxation rates for iron-supplemented and unsupplemented parental cells. However, a  
statistically significant influence of iron-supplementation existed for  R2
*
 (p < .01) and R2
ʹ
  
(p < .001) in cells overexpressing MagA as shown in Figure 2.4. For R2 the influence of iron  
supplementation showed only a trend (p < .05) when accounting for multiple comparisons.  
R2
*
 provided the greatest absolute difference in MR relaxation rates and R2
'
 displayed the  
greatest relative difference. The significant effect of iron supplementation was found also by  
the non-parametric Mann-Whitney test.  
. 
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Figure 2.4. Transverse and longitudinal relaxation rates. Bar graphs indicate the change 
in all 3 transverse relaxation rates and the lack of change in longitudinal relaxation rate upon 
iron supplementation of parental and MagA-expressing cells. R2
*
 showed the greatest 
absolute difference between iron supplemented vs. unsupplemented cells, while R2
'
 showed 
the greatest relative difference between these cell groups. R1 is similar for all parental (n=2) 
and MagA-expressing (n=5) cell samples. Error bars represent SEM. The number of samples 
for parental+Fe, parental-Fe, MagA+Fe, MagA-Fe were 5, 5. 8 and 8 respectively for 
transverse measurements and 2, 2, 5 and 5 for longitudinal relaxation rate measurents.  
 for p < .001,  for p < .01 and  for p < .05 (trend). 
 
 The bar chart in Figure 2.4 shows the mean values of the transverse and  
longitudinal relaxation rates of parental and MagA-expressing cell samples both iron- 
supplemented and unsupplemented. Significant differences are observed between R2
*
  
(p < .01) and R2
ʹ 
(p < .001) for iron-supplemented MagA-expressing cells.  
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 Figure 2.5 illustrates a scatter plot of the individual transverse relaxation rates for  
each group. This scatter plot is presented in addition to the bar graph in Figure 2.4 (means  
and SEMs) in order to more completely show the variability of measurements. Although the  
transverse relaxation rates for iron-supplemented MagA-expressing cells were significantly  
higher than for unsupplemented MagA-expressing samples, there is nevertheless substantial  
variability in measurements especially when iron-supplemented. 
   For all cell types and culture conditions, R1 remained virtually constant between 
0.72- 0.81 s-1 and was not pursued as an indicator of cellular iron contrast. The scatter plots 
for R1 are not shown because variability was low for R1. 
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Figure 2.5. Scatter plot showing transverse relaxation rates for parental and MagA-
expressing cell samples both iron-supplemented and unsupplemented. This plot was 
included to illustrate the relatively large degree of variability in these rates especially for 
iron-supplemented MagA-expressing cells.  
 
 
 2.3.2 Trace Element Measurements 
 In MagA-expressing cells, cultured in the absence of iron supplementation, ICP-MS  
analysis indicated 0.047 ± 0.006 μg Fe/mg protein (n=7; mean ± SEM) and 0.249 ± 0.047 μg  
Zn/mg protein. In contrast, the presence of iron supplementation in MagA-expressing cells  
increased iron content to approximately 0.755 ± 0.157  μg/mg protein while level of zinc  
stayed at approximately 0.135 ± 0.023 μg /mg protein (Table 2). Additional data for the ratio  
of iron/zinc in non-supplemented cultures showed lower values compared to the  
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supplemented ones. Samples both in presence and absence of iron when evaluated using a  
student’s t test showed significance at p < .01 for iron, but not significant for zinc. 
Table 2. Trace element analysis^ of cells cultured in the presence or absence of iron 
supplementation.* 
 
Sample Iron
# 
Zinc
#
 Fe/Zn N 
P 0.250 0.117 2.14 1 
P+Fe 0.475 0.107 4.44 1 
MagA 0.047 ± 0.006 0.249 ± 0.047 0.19 7 
MagA+Fe 0.755 ± 0.157 0.135 ± 0.023 5.60 7 
^ Data were collected using either ICP-MS. 
* Cells were incubated in the presence (+Fe) or absence of 250 μM ferric nitrate 
#  Elemental analysis is reported as μg/mg protein; mean ± SEM in case of MagA-expressing 
samples only.  
 
 Figure 2.6 illustrates a plot of the transverse relaxation rates R2
*
, R2 and R2
ʹ
 vs iron  
content, for iron supplemented and unsupplemented MagA-expressing cell samples. 
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Figure 2.6. Relaxation rates (A) R2*, (B) R2 and (C) R2ʹ vs iron content for MagA-
expressing cell samples. All the graphs showed correlation of relaxation rates with iron 
content (μg per mg of protein) in MagA-expressing cell samples both iron-supplemented and 
unsupplemented (empty diamonds = MagA and filled diamonds = MagA+Fe).  
 
 As shown in Figure 2.6, a significant correlation ( p < .005) between R2ʹ and iron  
content (normalized to protein content) was observed.  
2.4 Discussion 
 The results of this study may help to design and optimize methods for tracking  
gene-based iron-labeled cells in vivo. Relaxation rate measurements, a quantitative approach  
to assess iron-related contrast, may be helpful to track iron-loaded cells more precisely in the  
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developing tumor. As advances in MR hardware, sequences and contrast agents [4] progress,  
so too will  molecular MRI. In this study, to approach  that goal, measurements of relaxation  
rates were performed to explore the potential for contrast enhancement in cancer cells  
utilizing overexpression of MagA, a bacterial gene. 
 Using phantoms of compact cell pellets, we quantified cellular MR contrast using  
relaxation rate measurements. Longitudinal relaxation rates were influenced very little, if  
any, by the cellular iron and this is consistent with the literature [5]. On the other hand,  
transverse relaxation rates were strongly affected by iron supplementation for  
MagA-expressing cells (Figure 2.4). For this cell type the elemental iron content was also  
higher in supplemented versus unsupplemented samples.  
 Every cell maintains their normal redox states which when disturbed, toxic effects  
like oxidative stress occur, damaging components of cells. Changes in cellular zinc levels  
provide one indicator of oxidative stress [6]. In our analyses, we showed specific iron uptake  
and relatively constant levels of zinc in iron-supplemented MagA-expressing cells, consistent  
with little or no redox cytotoxicity. 
 In this study, the relaxation rates and iron levels for MagA-expressing cells  
investigated in presence of iron-supplementation demonstrated the potential for taking up 
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iron, leading to MRI contrast. This quantitative result was consistent with a previous study  
where the potential of MagA-expression to produce intracellular contrast in mouse  
neuroblastoma (N2A) cells was studied [1]. As well, the iron-related contribution to   
transverse relaxation increases with field strength, thus, contrast differences between gene  
expression and controls should be greater at higher fields. 
 R2 measurements have previously been reported in 293FT cells expressing MagA  
(approx. 20 s-1, 3 T, n=4) [7]. The values for MagA-expressing cells compare well  
with the findings in this thesis; however, my results (Figure 2.4) indicated that R2 alone  
provides the weakest index of MR contrast activity based on student’s unpaired t-test.  
Measures of R2
*
 and R2
' 
were found to provide the most statistically significant changes in  
cellular contrast upon iron supplementation. In addition, relative changes in R2
'
 were larger  
than those in R2, suggesting the potential of R2
' 
for better iron-related specificity, as  
previously suggested for human brain regions with high iron [2]. This may be important for  
in vivo cell tracking and optimization of molecular MRI.  
 In our study, the constitutive expression of MagA in MDA-MB-435 cells was  
unhampered by protein tags and previously confirmed to provide high levels of MagA  
mRNA expression relative to β-actin using reverse transcription polymerase chain reaction  
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(RT-PCR). The constitutive expression of fusion protein, enhanced green fluorescent protein  
(EGFP)-MagA, has been confirmed in both mouse neuroblastoma N2A cells [1] and in  
MDA-MB-435 cells (unpublished results). Using the MTT assay, it has also been shown that  
the proliferation of transfected tumor cells is not altered by the activities of MagA expression  
[1]. In our study we detected the activity of MagA using relaxation rate measurements. In  
addition, iron uptake in MagA-expressing cells was greatly influenced by the presence of an  
iron supplement (250 μM ferric nitrate).  
 In a mouse xenograft model of tumor growth, Rohani et al. [8] showed that MagA  
expression generated a peak in MR contrast in vivo during the second week of tumor growth,  
similar to the contrast derived from the expression of modified ferritin subunits lacking iron  
response elements to enable continuous expression. Beyond 3 weeks post-injection, MR  
contrast in the parental tumor also increased, reducing the benefit of contrast gene expression  
in larger tumors. To improve image analysis, relaxation rate measurements using optimal  
measures provides an additional tool for assessing MagA-derived MR contrast and could be  
implemented for a longitudinal study as that by Rohani et. al.[8].  
 Gene-based contrast like MagA overexpression may be helpful in tracking  
metastasis in the white matter of brain for breast cancer [9]. When a gene-based iron contrast  
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responds clearly to iron supplementation, it becomes suitable for revealing changes in iron  
homeostasis. As an example, in a study by Shpyleva et al., they reported changes in the level  
of ferritin subunits between epithelial and mesenchymal breast tumor cell lines [10]. In that  
study MagA overexpression might be a preferred tool to track cells in order to avoid  
interference with the cell biology related to cancer.  
 The finding of this work that relaxation rates for MagA-expressing cells can be  
distinguished from parental controls is encouraging, however for in vivo detection the  
challenge will be to distinguish MagA-expressing cells from surrounding tissue. In vivo there  
is an additional challenge of distinguishing MagA-expressing iron labeled cells from  
endogenous iron, where the level of endogenous iron will depend on the particular organ to  
be imaged. For in vivo image acquisition, relaxation rate measurements will encounter  
further limitations. Background field inhomogeneities due to susceptibility differences  
between tissues will always contribute to R2
*
 measurements unless correction procedures are  
applied [11]. Furthermore, the measurement of R2 would require long acquisition times.  
 Although transverse relaxation rates vary as a function of  tissue iron [12], 
R2 in particular is affected by other factors in the tissue or cell, such as water content 
reflecting proton density, subcellular compartmentalization and water-protein interactions. 
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By comparison, R2
'
 is mostly influenced by sources of magnetic field inhomogeneity. If  
sources of macroscopic inhomogeneity are minimized, as done here by using a spherical  
phantom, then R2
'
 should be influenced mostly by microscopic sources of inhomogeneity,  
which in our samples should be from iron particles. In order to correct for macroscopic  
inhomogeneities in-vivo, post processing methods have been developed [11]. This involves  
the use of the phase of the gradient echo signals, for which no added acquisition is required.  
In a study on small animal imaging this same idea was adapted where R2
*
 and R2
ʹ  
measurements from superparamagnetic iron nanoparticles labeled cancer cells were reported  
[11].   
 The results reflected in Figure 2.6, supported the notion that transverse relaxation  
rates are strongly influenced by the amount of iron [2]. Among all the transverse relaxation  
rates, R2
ʹ
 showed the strongest correlation with the amount of iron for MagA-expressing  
cells. This suggests the potential of R2
'
 for better iron-related specificity for imaging of  
gene-based iron-labeled cells and is consistent with, the effect of iron in human brain regions  
with high iron [2].  
 From our iron level measurements expressed as μg Fe/mg protein we can estimate  
the amount of iron per cell in our samples. Our nunc wells had approximately 60 × 10
6
 cells  
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in a volume of π(3mm)2 (6 mm) ≈ 170 μL, and this corresponds to 3 × 10-9 g/cell assuming a  
density of 1.0 g/ml. If we also assume that approximately 20% of the mass of a cell is protein  
then each cell has approximately 6 × 10
-7
 mg protein/cell. Therefore our highest iron level for  
MagA+Fe (≈1.4 μg Fe/mg protein) corresponds to approximately 0.84 pg Fe/cell which is  
similar to the levels reported by Zurkiya et al [7] (≈0.6 μg Fe/cell) and almost 100 times  
smaller than reported for SPIO loading [13]. The number of cells in each MRI voxel  
can be estimated from the number of cells/volume (60 × 10
6
 /170 μL) and the volume of each  
voxel (≈0.5 μL) leading to an estimate of ~ 2 ×105 cells/ voxel. In a separate report [20] we  
demonstrated voxel-by-voxel mapping of these relaxation rates indicating that we can easily  
detect 2 ×10
5 
cells with this setup. However our phantom included approximately 400g of gel  
which acted as a large source of noise. If we were imaging a mouse brain for example (~10 g)  
inside a small RF coil we would have greatly increased signal-to-noise and could detect  
perhaps ~ 104 cells and perhaps as low as 103 cells especially at higher field strength and with  
more optimized acquisitions. 
 The principle iron import mechanism in mammals, via the transferrin receptor, is  
universally expressed in almost all cells [14], with increased levels of transferrin expression  
in cells that are propagating rapidly  and require iron in order to function [15]. Tumor cells  
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when compared to healthy tissue have low levels of ferritin expression with high levels of  
transferrin receptor[16, 17]. These changes related to iron uptake regulation, storage and  
distribution support rapid cell proliferation, for example by supplying iron as a cofactor for  
ribonucleotide reductase and DNA synthesis [18, 19]. The propensity of proliferating cells  
toward iron uptake may be used to best advantage in cancer cell tracking by MRI and the  
development of gene-based contrast. In a related study from my work, a drop in transferrin  
receptor was detected in parental (data not shown) as well as engineered cells following  
culture in the presence of iron supplementation [20]. Therefore, the activity of MagA has  
elicited the same homeostatic response as expected of an increase in ferritin storage. In spite  
of this, a statistically significant level of MR contrast enhancement was achieved suggesting  
that MagA may function outside the regulatory control of iron binding proteins. In the case of  
MagA activity, the lack of cellular regulation may be reflected in greater fluctuation in iron  
levels and therefore in MR contrast. This in turn may result in a relatively large degree of  
variability in the transverse relaxation rates of the iron-supplemented MagA-expressing cells  
(Figure 2.5). The ability of MagA to circumvent key features of mammalian iron regulation,  
without causing cytotoxicity, will bode well for future development of gene-based contrast.  
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Chapter 3 
Summary and Future work 
3.1 Summary of Findings 
 In summary, we have used the MagA gene from magnetotactic bacteria to impart 
magnetic sensitivity to mammalian cancer cells and provide groundwork for cell tracking by  
MRI. Our study reported the use of transverse relaxation rate measurements as an effective  
tool for quantifying the contrast enhancement previously reported [1] in MDA-MB-435 cells  
overexpressing MagA, under iron supplemented conditions. Although transverse relaxation  
rate measurements revealed an increased value for iron-supplemented MagA-expressing cells  
compared to its unsupplemented and parental controls, longitudinal relaxation rates failed to  
discriminate between these cell types regardless of the level of extracellular iron. Also R2ʹ  
quantification of MagA-expressing iron-labeled cells showed a potential to be more  
characteristic of iron, consistent with previous studies of tissue and suggesting that R2ʹ has  
better iron-related specificity than other relaxation rates [2].  
 Our results also suggested a relatively large degree of variability in both transverse  
relaxation rate and the intracellular iron content of MagA-expressing cells cultured in the  
presence of iron supplementation. Further work to determine the sources of variability will  
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increase the potential of R2ʹ as an indicator of MagA-derived contrast and may provide gene- 
based contrast for MRI which in future may help to detect cell growth and differentiation  
more effectively in vivo. 
3.2 Future Work 
 Chapter 2 establishes a method of detecting gene-based iron-labeled cells in-vitro 
through quantifying the MRI signal changes associated with cellular iron uptake by MagA- 
expressing cells. A natural extension of this work would be its implementation for cell- 
tracking in-vivo such as in the case of a mouse model of tumour growth from transplanted  
cells [1]. Previously reported methods [3] for correcting R2ʹ for “macroscopic” magnetic  
field inhomogeneities within tumor tissue, where the iron-related contributions to R2ʹ are  
expected to be minimal can be implemented and tested in the absence of iron  
supplementation. There are some challenges related to R2 and R2
ʹ
 measurements in vivo with  
R2 requiring long acquisition times unless a multi-echo acquisition is used and R2
ʹ
 being  
influenced mostly by magnetic field inhomogeneties that can be corrected with the use of the  
phase of the gradient echo signals. Also, relaxation mapping reported recently [4] using  
optimal measures provides an additional tool for improving image analysis. R2 and R2
ʹ
 these  
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measurements can also be performed in mice bearing subcutaneous tumors on the hind limb  
expressing MagA. In that case parental tumors on the opposite flank may provide  
physiologically-relevant controls. Based on the results of this thesis, it can be hypothesized  
that both R2 and R2ʹ values will be higher in MagA-expressing tumors than in controls, and  
that the relative differences between MagA-expressing and parental cells will be higher for  
R2ʹ.  
 This study can be extended for repetitive imaging of tumor growth and metastasis  
in small animal model, with the goal of tracking changes in relaxation rates longitudinally  
with time. In this instance, utilization of a MagA construct tagged with the hemagglutinin  
(HA) epitope and commercial antibodies, will be suitable to correlate regions within the  
tumor exhibiting MR contrast with localization of HA-MagA-expressing cells. The potential  
of a dietary iron supplement for improving tumor cell contrast can also be examined.  
 In this particular thesis all the MR measurements were done at 3T. Previous studies  
showed that R2 ′ in tissue increased with field strength
 
 [2] , suggesting that stronger R2 ′  
differences between MagA and parental or other cells or tissues will be found at higher  
fields. Thus for implementation of relaxation measurements for in-vivo tracking may be  
better at higher fields. 
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 In mammalian cells, effective MR contrast derived from the overexpression of   
iron handling protein(s) would benefit from a better understanding of which combination of  
magnetotactic bacterial genes will (1) sequester iron within a membrane-enclosed vesicle and  
(2) allow biomineralization of iron in the presence of mammalian iron homeostasis.  
Magnetosome gene knock-out studies [5] suggests the probability that a subset of genes may  
be used to generate a minimal compartment in multiple cell types that would permit iron  
biomineralization for non-invasive medical imaging with MRI. 
 Is it possible for magnetosome-like particles to be reproduced in mammalian cells  
in a safe and efficient manner for biomedical molecular imaging? Further research on  
magnetotactic bacteria will provide critical information upon which this question may be  
judged. Taking current knowledge into consideration, magnetosome-like vesicles in  
eukaryotic cells should a) be composed of a lipid bilayer that interacts with cytoskeletal  
protein to impart stability, b) be exposed to cytoplasmic or extracellular precursors for  
biomineralization, c) impart magnetic properties to the cell, and d) be non-essential for cell  
survival. The strict regulation of iron in vivo is advantageous in several ways, permitting  
genetic manipulation of its localization, crystallization and association with key cellular  
processes. We need additional information regarding prokaryotic iron binding proteins  
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that can be genetically engineered to handle iron in a eukaryotic environment. We also need  
to understand more about magnetic particles in mammalian and vertebrate systems. 
The manner in which magnetite is dismantled during cell turnover or when magnetosome- 
like reporter gene expression is turned off will be important to understand for effective  
measurement of cell tracking and of cellular activity. In principle, regulation of crystal size  
and shape should influence MRI. However, recreating magnetism whereby cells move in a  
magnetic field is not necessarily the goal of MR contrast. For medical imaging, we may not  
need to form the same single magnetic domain that magnetotactic bacteria require for  
magnetotaxis. This function requires larger magnetite crystals, approximately 50-100 nm in  
length and their alignment along the magnetosome filament [6]. Crystal sizes that induce  
superparamagnetic properties are approximately 30 nm in length and suitable for MRI and  
altering proton spins. While an elaborate set of reactions and protein-protein interactions  
contributes to the formation of uniform magnetite crystals, some redundancy in the protein  
architecture of magnetosomes raises the possibility that a more basic set of magnetosome  
genes might be sufficient for iron biomineralization and compartmentalization within a lipid  
vesicle. Understanding the role of each magnetosome gene will foster future pre/clinical  
applications in MRI. 
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 Development of these non-invasive cellular imaging methods is relevant to the study  
of cancer progression. Preclinical models of aggressively growing cancers may be assessed  
sooner in their development with respect to size or the change in cellular activity using  
MagA overexpression as a tool. In future, this could potentially be applied to small animal  
MRI to examine MagA reporter gene expression in developing tumor. 
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Research Project: “MRI Relaxation Rates: A Quantitative Approach 
to Track Tumour Cells Expressing MagA.” 
 
08/07 – 12/09              M.S. in Physics 
Indiana University of Pennsylvania, Indiana, PA, USA 
Supervisor: Feng Zhou, PhD 
Thesis: “A Fiber-Optic Q-Switch Based On Electro-optic Ceramic   
For Q-Switched Fiber Lasers” 
 
02/05 – 01/06              B.Ed. in Education 
University of Calcutta, West Bengal, India 
 
05/98 – 05/02              B.Sc. (Honors) in Physics 
University of Calcutta, West Bengal, India 
 
 
SCHOLARSHIPS AND AWARDS 
05/12 – 04/14             Western Graduate Research Scholarship (WGRS) 
University Of Western Ontario, London, ON 
08/07 – 12/09             Graduate Assistanceship  
Indiana University of Pennsylvania, Indiana, PA, USA 
2008                            Honored Graduate Student Award for Research Poster Presentation 
Indiana University of Pennsylvania, Indiana, PA, USA 
 
WORK EXPERIENCE 
09/11 – 04/12             Research Assistant under Dr. Neil Gelman and Dr. Donna Goldhawk 
Lawson Health Research Institute, Imaging Program, London,ON 
 MRI sequence optimization, data acquisition and analysis. 
 Development of MRI application in molecular imaging. 
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 Cell Culture 
 Collected data using MRI for cell imaging research. 
08/07 – 12/09              Graduate Teaching Assistant 
 Department of Physics, Indiana University of Pennsylvania, Indiana,   
PA, USA 
 Tutored undergraduate students for lab work in 
introductory courses and helped them to solve class 
assignments. 
 Presented research work through thesis defense, 
poster presentation and projects to large audiences. 
 Applied programming skills to solve problems in 
physics using database, object oriented and 
simulation software. 
 Assisted faculty members in their research work and 
helped them in grading lab reports. 
 
PUBLICATION 
1. Sengupta, A., Quiaoit, K., Thompson, R. T., Prato, F. S., Gelman, N. & 
Goldhawk, D.E., Biophysical features of MagA expression in mammalian cells: 
implications for MRI contrast. Frontiers in Microbiology, 2014. 5(29). 
2. Goldhawk, D., Rohani, R., Sengupta, A., Gelman, N., & F.S. Prato. Using the  
magnetosome to model effective gene-based contrast for magnetic resonance  
imaging. Rev. Nanomed. Nanobiotechnol. 4: 378-388 (2012) - [Published  PMID: 
22407727] 
 
PRESENTATIONS 
POSTERS: 
 
1. Sengupta, A., Thompson, R.T., Prato, F.S., Goldhawk, D., & N. Gelman. 
Irreversible and Reversible Transverse Relaxation Rates Alter with Fractional 
Volume of MagA-expressing Cancer Cells London Health Research Day, 
London, Ontario, Canada, March 19, 2013. 
2 .  Sengupta, A., Rohani, R., Thompson, R.T., Prato, F.S., Goldhawk, D., & N. 
Gelman. Transverse and Longitudinal MRI Relaxation Rates in MagA-expressing 
Human Cancer Cells. World Molecular Imaging Conference, Dublin, Ireland, 
September 5-8, 2012. 
3. Sengupta, A., Rohani, R., Thompson, R.T., Prato, F.S., Goldhawk, D., & N. 
Gelman. Iron Labeling of Human Cancer Cells with the MagA Reporter Gene 
Leads to Increased MRI Relaxation Rates. London Imaging Discovery Conference, 
London, Ontario, Canada, June 27, 2012. 
4. Sengupta, A., Rohani, R., Thompson, R.T., Prato, F.S., Goldhawk, D., & N. 
Gelman. MRI Relaxation Rates in Tumor Cells Expressing MagA Reporter 
Gene. London Health Research Day, London, Ontario, Canada, March 20, 2012. 
5. Sengupta, A., Rohani, R., Thompson, R.T., Prato, F.S., Goldhawk, D., & N. 
Gelman. MRI Relaxation rates in Tumor Cells Expressing the MagA Reporter 
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Gene. ISMRM ScientificWorkshop Miami Beach, Florida, USA, January, 2012. 
ORAL: 
1. Sengupta, A., Rohani, R., Thompson, R.T., Prato, F.S., Goldhawk, D., & 
N. Gelman. MRI Relaxation Rates in Tumor Cells Expressing MagA 
Reporter Gene. ImNO, 10th Imaging Symposium Toronto, Ontario, 
Canada, February 13-14, 2012. 
 
PROFESSIONAL ASSOCIATION 
12/11 – Present              International Society for Magnetic Resonance in Medicine      
            (ISMRM) 
13/02 – Present              World Molecular Imaging Society (WMIS) 
 
 
TECHNICAL SKILLS 
Computer:     MS Office, Matlab, C++ 
Laboratory:   Cell Culture Techniques 
 
CERTIFICATION 
1.   Basic Animal Care and Use Course (including sterile injections techniques 
and basic handling, mouse injections and 
techniques,  mouse anesthesia  and 
assessment  monitoring and intervention) 
2.   Biosafety training 
3.   Workplace Hazardous Materials Information System (WHMIS) for laboratory 
workers. 
 
LANGUAGES 
English, Bengali and Hindi – fluent in speaking, reading and writing 
 
 
 
 
 
 
 
 
 
 
 
